Mesothelioma & Pharmaceuticals

Opioid Trial on Hold As Possible Deal Struck

[:en]Another settlement deal in the opioid epidemic may be on the horizon between pharmaceutical distributors, a developer, and the federal government. 

Trial Set to Begin Today

The first day of the trial was set to begin this morning in U.S. District Court in Cleveland, Ohio. The claims were brought against distributors such as AmerisourceBergen according to an article from Denver 9 News. Some defendants were left out of the deal, like distributor Henry Schein and popular pharmacy brand Walgreens. At this time, it is unknown if the trial will still go forward. 

A Different Angle

This trial is set to look at the opioid crisis in a different way. Instead of focusing solely on pharmaceutical developers and their marketing of opioids, this trial looks at how distributors of these drugs also contributed to the epidemic. The article also mentioned how pharmaceutical company Purdue Pharma recently came to a possible settlement agreement with the federal government last month. The agreement has the potential to be worth up to $12 billion, however may be reworked due to the company now having filed for bankruptcy.

Injured from Opioids or other Bad Drugs?

If you or someone you know has suffered an injury through the use of an opioid or another pharmaceutical drug, contact our team at (303)-999-9999 or (303)-835-9342 to schedule a free consultation. Click here to view our practice area page on pharmaceuticals for more information.  


Leave a Reply